Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia

This study has been terminated.
Information provided by (Responsible Party):
Pronova BioPharma Identifier:
First received: October 24, 2013
Last updated: October 7, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2014
  Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: September 21, 2015